HSPA5 and breast cancer: Also the peptides WIFPWIQL and WDLAWMFRLPVG are able to bind GRP78 on the cell surface and have been employed successfully in in vivo models of prostate and breast cancer for the delivery of a cell death-inducing peptide (Arap et al., 2004).